Chemomab Therapeutics (CMMB) Dividends Paid - Common (2018 - 2019)
Chemomab Therapeutics' (CMMB) quarterly Dividends Paid - Common came in at -$3.8 million in Q3 2019, up 56.29% YoY from -$2.4 million in Q3 2018, and up 56.29% on a QoQ basis from -$8.6 million in Q3 2018.
Chemomab Therapeutics (CMMB) Dividends Paid - Common (2018 - 2019) Analysis & Trends
Chemomab Therapeutics (CMMB) has 2 years of Dividends Paid - Common data on file, last reported at -$3.8 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | Chemomab Therapeutics | 13.62 Mn | 3.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -3.77 Mn |
| Sep 30, 2019 | -3.77 Mn |
| Sep 30, 2018 | -8.62 Mn |
| Sep 30, 2018 | -8.62 Mn |